125
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition

, , , , , , , , , & show all
Pages 113-129 | Received 24 Dec 2019, Accepted 14 Mar 2020, Published online: 13 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bingqian Li, Huili Shao, Lei Gao, Huan Li, Huagang Sheng & Liqiao Zhu. (2022) Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Delivery 29:1, pages 2130-2161.
Read now

Articles from other publishers (5)

Siqi Wu, Zhe Sun, Zehuai Guo, Peiqin Li, Qianqian Mao, Yang Tang, Hongyu Chen, Huiting Peng, Sisi Wang & Yang Cao. (2023) The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review. Journal of Ethnopharmacology 314, pages 116565.
Crossref
Girish Kumar, Tarun Virmani, Ashwani Sharma & Kamla Pathak. (2023) Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers. Pharmaceutics 15:3, pages 889.
Crossref
Mehrdad Hashemi, Fatemeh Ghadyani, Sahar Hasani, Yeganeh Olyaee, Behnaz Raei, Marzieh Khodadadi, Maryam Fallah Ziyarani, Fatemeh A. Basti, Alireza Tavakolpournegari, Arash Matinahmadi, Shokooh Salimimoghadam, Amir Reza Aref, Afshin Taheriazam, Maliheh Entezari & Yavuz Nuri Ertas. (2023) Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 80, pages 104112.
Crossref
Xi Ye, Xin Chen, Ruixi He, Wangyang Meng, Weidong Chen, Fengling Wang & Xiangyun Meng. (2022) Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin. Frontiers in Pharmacology 13.
Crossref
Saeideh Allahyari, Fahimeh Zahednezhad, Mohamad Khatami, Nastaran Hashemzadeh, Parvin Zakeri-Milani & Francesco Trotta. (2022) Cyclodextrin nanosponges as potential anticancer drug delivery systems to be introduced into the market, compared with liposomes. Journal of Drug Delivery Science and Technology 67, pages 102931.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.